SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-031021
Filing Date
2019-06-14
Accepted
2019-06-14 16:48:09
Documents
1
Period of Report
2019-06-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv523632_4.html 4  
1 OWNERSHIP DOCUMENT tv523632_4.xml 4 3549
  Complete submission text file 0001144204-19-031021.txt   5002
Mailing Address 375 PARK AVE NEW YORK NY 10152
Business Address
ROSENWALD LINDSAY A MD (Reporting) CIK: 0000941841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38128 | Film No.: 19899458

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Issuer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations